|
HS Code |
660787 |
| Cas Number | 153-91-7 |
| Molecular Formula | C7H5BrN4O2 |
| Molecular Weight | 257.05 |
| Iupac Name | 8-bromo-1H-purine-2,6-dione |
| Synonyms | 8-Bromoxanthine, 8-Bromo-2,6-dioxypurine |
| Appearance | Off-white to light yellow powder |
| Melting Point | 330-332°C (decomposes) |
| Solubility In Water | Slightly soluble |
| Storage Temperature | 2-8°C |
| Purity | Typically >98% |
| Smiles | C1=NC2=C(N1)C(=O)N(C(=O)N2)Br |
| Pka | Approx. 8.6 |
As an accredited 8-Bromoxanthine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 8-Bromoxanthine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
The world of biochemical research moves fast. New molecular tools help us question old assumptions and pioneer new pathways. Among these tools, 8-Bromoxanthine carves out a distinct niche. This xanthine derivative stands out for its highly targeted interactions within cellular signaling—an aspect that’s helped shape both published work and industry studies. With a backbone rooted in purine chemistry, 8-Bromoxanthine offers both familiarity and something undeniably fresh to experimental design.
Researchers have tailored 8-Bromoxanthine for unique receptor testing and enzyme inhibition. Its bromine atom at the eighth position isn’t just a modification for the sake of novelty; this subtle change impacts molecular behavior. Compared to standard xanthine compounds like caffeine or theobromine, the difference becomes evident in receptor selectivity and potency. Focusing on phosphodiesterase activity and adenosine receptor dynamics, this derivative challenges the expectations set by more generic reagents.
Lab experience tells us that results often hinge on the tools at hand. The surprise sometimes comes from a simple substitution on a proven scaffold. The brominated structure of 8-Bromoxanthine produces shifts in binding affinity and selectivity that set it apart from better-known purines. This ability to modify selectivity without wholesale reworking of protocols makes it an attractive option for those chasing new questions about cell signaling or metabolic pathways.
The research-grade 8-Bromoxanthine available today meets purity benchmarks expected by academic and industrial labs—solubility in common lab solvents, a crystalline appearance, and dependable batch-to-batch consistency. But these technical points only matter because they serve a larger mission. Anyone who’s juggled multiple variables in a cell signaling experiment knows the headache of inconsistent control reagents. The structure of 8-Bromoxanthine, with its single halogen substitution, offers both predictability and potent performance in a bench setting.
Certain xanthine analogs muddy the waters. Theobromine and caffeine have cropped up in everything from coffee to cosmetics, but their broad activity complicates interpretation. 8-Bromoxanthine carves out its calling card in narrower margins. Whether you’re teasing apart adenosine receptor antagonism or probing phosphodiesterase inhibition, this molecule provides a focused approach with fewer confounding side effects. Researchers looking to refine their data can trust the nuances that 8-Bromoxanthine delivers.
Those who have worked with a vast range of xanthine analogs know the frustration of signal noise and ambiguous results. I’ve run into plenty of hurdles, from solubility issues to weird off-target events. In the practical grind of titration assays and receptor binding tests, 8-Bromoxanthine’s stability and selective potency can make the difference between a clear conclusion and another ambiguous “maybe.” Beyond chemical theory, it feels good to work with compounds that let you focus on exploration, not troubleshooting solubility or decomposition.
The accessibility of high-purity 8-Bromoxanthine has let more research teams step up to nuanced experiments once limited to big-budget labs. Academic scientists, graduate students, and industry technicians find clarity in their results. Problems that once required expensive or highly specialized analogs can often be tackled with this compound, thanks in part to suppliers raising the bar on product consistency.
Adenosine, caffeine, and related compounds have monopolized attention for years. They’re cheap, widely available, but often too indiscriminate in their biological effects. Even the well-known drug theophylline, famous for respiratory medicine, works across too broad a spectrum to satisfy niche research needs. The inclusion of a bromine atom at the eighth position in xanthine’s framework doesn’t sound revolutionary, but this change widens the experimental playing field. Those working on adenosine A1 or A2A receptors notice significant differences in receptor antagonism profiles compared to standard xanthines.
Through casual conversations at conferences and in collaborative work across multiple labs, distinct patterns have emerged. Xanthines without the C-8 bromine lack both the selectivity and the punch seen with 8-Bromoxanthine. That’s not just chemical curiosity—it shapes entire research directions, letting teams ask questions about selective pathway inhibition without second-guessing cross-talk on unrelated receptors. This improved targeting has opened up studies into neuroprotection, cardiovascular signaling, and beyond.
One of the most consistent challenges in academic and industry environments is managing reproducibility. With so many factors at play—supplier variation, lab technique, even the season influencing humidity—minor changes make a real difference. Suppliers who provide 8-Bromoxanthine at high purity help smooth out at least one variable. Proper storage in airtight containers, away from strong light and moisture, preserves the consistency and ensures the next experiment builds faithfully on the last.
If solubility in aqueous buffers presents a hurdle, experienced researchers dissolve the compound in a small amount of DMSO or another organic co-solvent, followed by dilution into the assay medium. This practical tip, earned from stubborn afternoons in the lab, saves both time and sample. By focusing on these practical aspects, scientists avoid unnecessary troubleshooting and push research closer to meaningful insights.
A single molecular tweak—adding bromine at position eight—has ripple effects beyond basic curiosity. Data generated with 8-Bromoxanthine play roles in drug discovery, toxicology, and signaling pathway mapping. For those in pharmaceutical pipeline roles, better selectivity matters for both target validation and compound screening. Biologists mapping the details of cyclic nucleotide regulation appreciate the value this selectivity brings, especially as complex pathways reveal hidden links through targeted inhibition or receptor antagonism.
The story of 8-Bromoxanthine isn’t just about molecular novelty. It sits at the intersection of practicality and rigor. Its impact shows up in the detail work of drug development and the daily challenge of advancing disease models. Every successful experiment with this compound nudges research a step closer to applications that improve health or develop new diagnostic strategies.
Looking back at the history of xanthine derivatives, the research world keeps finding creative ways to coax new behavior from familiar frameworks. I’ve spent years navigating the intricacies of purines—sometimes with frustration, often with a sense of discovery. Classic xanthines like caffeine and theophylline remain staples, filling roles in sports medicine and neurological research, but their lack of selectivity is both a strength and a limitation. By narrowing focus, 8-Bromoxanthine redefines what’s possible in the realm of signal transduction.
Repeated exposure in seminars and publications hammers home the impact that such derivatives can have, especially on purinergic signaling and phosphodiesterase research. The subtleties in how a compound like 8-Bromoxanthine interacts with both adenosine receptors and cyclic nucleotide turnover set it apart for theory-driven and translational projects alike. This makes it more than another research reagent—it’s often a catalyst for new directions in hypothesis-driven science.
Peer sharing often tells us as much as product handbooks. My own work has benefited from open forums and direct email exchanges where scientists troubleshoot unusual side effects or report unexpected results. Such community-driven insight now shapes much of the conversation around 8-Bromoxanthine, letting researchers waste less time repeating avoidable mistakes. Standard operating procedures have evolved, narrowing down the solvent systems that support both stability and bioactivity while minimizing artifacts.
Incorporating feedback into experimental workflows improves overall project quality. The cumulative knowledge—some earned through trial and error, some freely shared—makes the difference between a stalled project and a publication-ready data set. The move toward open science, paired with the rise of reliable molecular tools, creates an environment where 8-Bromoxanthine finds a real home.
Undergraduate and graduate laboratories need access to trustworthy and distinct chemical tools. My years guiding students through basic pharmacology assays or signal transduction labs have illustrated how key a reliable reagent can be. 8-Bromoxanthine offers a way to teach critical concepts like receptor selectivity, competitive inhibition, and the value of molecular substitution—all with a single compound.
Instructors and research mentors see tangible benefits. By using 8-Bromoxanthine in coursework or capstone projects, learners engage with genuine scientific questions, not just rote lab exercises. This real-world engagement helps prepare the next generation of scientists to think more critically about both experimental design and molecular function.
The story of 8-Bromoxanthine doesn’t stop with its current uses. Already, exploratory work investigates its potential in new contexts, from probing neurodegenerative disease pathways to questioning myocardial stress responses. As teams bring more creative questions to the table, this molecule continues to prove its versatility.
Scientific publishing now benefits from research featuring reproducible, selective reagents like 8-Bromoxanthine. Novel uses pop up in unexpected corners—enzymology, gene editing, tissue engineering—because a dependable molecular backbone inspires trust. These collaborations span academic, start-up, and even regulatory sectors, all working to answer complex questions with sharper tools.
Safe handling of brominated compounds comes from grounded lab training, not just warning labels. This xanthine derivate earns respect: store it away from children, minimize skin contact, and always clean up spills promptly. Most reputable laboratories already operate under these guidelines, but a quick review before opening a new vial helps maintain both personal and data integrity.
My own bench time hammered home the importance of maintaining well-ventilated workspaces and monitoring solvent use. A culture of mindfulness means fewer accidents, better documentation, and ultimately, cleaner results.
Lab supply companies now recognize the growing demand for 8-Bromoxanthine. Improved bulk synthesis and purification methods have trimmed lead times and made large-amount purchasing easier. This expands access beyond a single market or continent, so collaborative projects can align protocols and share insights across borders without the confusion of using slightly different analogs.
Product literature focuses on purity, solubility, and delivery timelines, but it’s the road-tested reliability that drives true adoption. Procurement managers and principal investigators alike ask for feedback before large-scale purchases, relying on the experiences of colleagues and partner laboratories.
Published studies cite 8-Bromoxanthine not just for classic pharmacological profiling, but for real advances in cell imaging, metabolism research, and structural biology. These citations serve as a found-footage documentary—warts and all—on what the molecule can and cannot do. Systems biologists, chemists, and clinicians add their voices, building a stronger consensus about where this molecule delivers results without fuss.
Unlike some exotic or hard-to-source reagents, 8-Bromoxanthine exists in a robust ecosystem of peer-reviewed support. Experienced scientists keep adding new layers, troubleshooting points, and potential pitfalls to the literature. The community-driven wisdom keeps new adopters on a surer footing.
Looking at the landscape of molecular tools, 8-Bromoxanthine continues to earn its reputation not through showy marketing, but consistent, focused results. Its unique bromine substitution unlocks both receptor selectivity and practical convenience. From week-to-week in an active lab, or across the grind of long-term drug development, this reagent bridges the gap between theoretical chemistry and experimental biology.
Researchers, educators, and industry leaders count on well-characterized molecules to advance the next round of discoveries. With 8-Bromoxanthine, there’s not only a solution to persistent signaling puzzles, but a broader template for how molecular nuance shapes real progress. In a world where both accuracy and innovation matter, it stands as a testament to the value of subtle advancement in scientific supply.